APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neprilysin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neprilysin Market Outlook and Growth Opportunities 2026

Report ID 174016310419 December 2025198 pages

Choose your research edition.

Industry ResearchNeprilysin Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Neprilysin Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neprilysin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neprilysin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neprilysin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neprilysin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neprilysin market include Novartis AG, Theravance Biopharma Inc, Pharmaleads SA and Bioprojet SCR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neprilysin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neprilysin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neprilysin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neprilysin market size, projected growth trends, production technologies, key applications, and end-use industries.

Neprilysin Segment by Company

Novartis AG

Theravance Biopharma Inc

Pharmaleads SA

Bioprojet SCR

Neprilysin Segment by Type

TD-0714

STR-324

PL-265

LHW-090

Others

Neprilysin Segment by Application

Acute Heart Failure

Hypertension

Cancer Pain

Alzheimer's Disease

Others

Neprilysin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Neprilysin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neprilysin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neprilysin significant trends, drivers, influence factors in global and regions.

6. To analyze Neprilysin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neprilysin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neprilysin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neprilysin industry.

Chapter 3: Detailed analysis of Neprilysin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neprilysin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neprilysin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neprilysin Industry Trends Table 2. Neprilysin Industry Drivers Table 3. Neprilysin Industry Opportunities and Challenges Table 4. Neprilysin Industry Restraints Table 5. Global Neprilysin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neprilysin Revenue Share by Company (2021-2026) Table 7. Global Neprilysin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Neprilysin Sales Volume Share by Company (2021-2026) Table 9. Global Neprilysin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Neprilysin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neprilysin Key Company Manufacturing Base & Headquarters Table 12. Global Neprilysin Company, Product Type & Application Table 13. Global Neprilysin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neprilysin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of TD-0714 Table 18. Significant Companies of STR-324 Table 19. Significant Companies of PL-265 Table 20. Significant Companies of LHW-090 Table 21. Significant Companies of Others Table 22. Global Neprilysin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Neprilysin Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Neprilysin Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Neprilysin Sales Volume Share by Type (2021-2026) Table 26. Global Neprilysin Sales Volume Share by Type (2027-2032) Table 27. Global Neprilysin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Neprilysin Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Neprilysin Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Neprilysin Sales Value Share by Type (2021-2026) Table 31. Global Neprilysin Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Acute Heart Failure Table 33. Significant Companies of Hypertension Table 34. Significant Companies of Cancer Pain Table 35. Significant Companies of Alzheimer's Disease Table 36. Significant Companies of Others Table 37. Global Neprilysin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Neprilysin Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Neprilysin Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Neprilysin Sales Volume Share by Application (2021-2026) Table 41. Global Neprilysin Sales Volume Share by Application (2027-2032) Table 42. Global Neprilysin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Neprilysin Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Neprilysin Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Neprilysin Sales Value Share by Application (2021-2026) Table 46. Global Neprilysin Sales Value Share by Application (2027-2032) Table 47. Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Neprilysin Sales by Region (2021-2026) & (K Units) Table 49. Global Neprilysin Sales Market Share by Region (2021-2026) Table 50. Global Neprilysin Sales by Region (2027-2032) & (K Units) Table 51. Global Neprilysin Sales Market Share by Region (2027-2032) Table 52. Global Neprilysin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Neprilysin Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Neprilysin Sales Value Share by Region (2021-2026) Table 55. Global Neprilysin Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Neprilysin Sales Value Share by Region (2027-2032) Table 57. Global Neprilysin Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Neprilysin Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Neprilysin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Neprilysin Sales by Country (2021-2026) & (K Units) Table 62. Global Neprilysin Sales Market Share by Country (2021-2026) Table 63. Global Neprilysin Sales by Country (2027-2032) & (K Units) Table 64. Global Neprilysin Sales Market Share by Country (2027-2032) Table 65. Global Neprilysin Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Neprilysin Sales Value Market Share by Country (2021-2026) Table 67. Global Neprilysin Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Neprilysin Sales Value Market Share by Country (2027-2032) Table 69. Novartis AG Company Information Table 70. Novartis AG Business Overview Table 71. Novartis AG Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Novartis AG Neprilysin Product Portfolio Table 73. Novartis AG Recent Development Table 74. Theravance Biopharma Inc Company Information Table 75. Theravance Biopharma Inc Business Overview Table 76. Theravance Biopharma Inc Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Theravance Biopharma Inc Neprilysin Product Portfolio Table 78. Theravance Biopharma Inc Recent Development Table 79. Pharmaleads SA Company Information Table 80. Pharmaleads SA Business Overview Table 81. Pharmaleads SA Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pharmaleads SA Neprilysin Product Portfolio Table 83. Pharmaleads SA Recent Development Table 84. Bioprojet SCR Company Information Table 85. Bioprojet SCR Business Overview Table 86. Bioprojet SCR Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bioprojet SCR Neprilysin Product Portfolio Table 88. Bioprojet SCR Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Neprilysin Distributors List Table 92. Neprilysin Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Neprilysin Product Image Figure 2. Global Neprilysin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neprilysin Sales (2021-2032) & (K Units) Figure 5. Global Neprilysin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Neprilysin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. TD-0714 Image Figure 10. STR-324 Image Figure 11. PL-265 Image Figure 12. LHW-090 Image Figure 13. Others Image Figure 14. Global Neprilysin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Neprilysin Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Neprilysin Sales Volume Share by Type (2021-2032) Figure 17. Global Neprilysin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Neprilysin Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Neprilysin Sales Value Share by Type (2021-2032) Figure 20. Acute Heart Failure Image Figure 21. Hypertension Image Figure 22. Cancer Pain Image Figure 23. Alzheimer's Disease Image Figure 24. Others Image Figure 25. Global Neprilysin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Neprilysin Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Neprilysin Sales Volume Share by Application (2021-2032) Figure 28. Global Neprilysin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Neprilysin Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Neprilysin Sales Value Share by Application (2021-2032) Figure 31. Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Neprilysin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Neprilysin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Neprilysin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 36. North America Neprilysin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Neprilysin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Neprilysin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 42. South America Neprilysin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Neprilysin Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Neprilysin Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Neprilysin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Neprilysin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Neprilysin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Neprilysin Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Neprilysin Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • TD-0714
  • STR-324
  • PL-265
  • LHW-090
  • Others
Applications
  • Acute Heart Failure
  • Hypertension
  • Cancer Pain
  • Alzheimer's Disease
  • Others
Companies covered
  • Novartis AG
  • Theravance Biopharma Inc
  • Pharmaleads SA
  • Bioprojet SCR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neprilysin Sales Value (2021-2032)
  4. 1.2.2 Global Neprilysin Sales Volume (2021-2032)
  5. 1.2.3 Global Neprilysin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neprilysin Market Dynamics
  1. 2.1 Neprilysin Industry Trends
  2. 2.2 Neprilysin Industry Drivers
  3. 2.3 Neprilysin Industry Opportunities and Challenges
  4. 2.4 Neprilysin Industry Restraints
3 Neprilysin Market by Company
  1. 3.1 Global Neprilysin Company Revenue Ranking in 2025
  2. 3.2 Global Neprilysin Revenue by Company (2021-2026)
  3. 3.3 Global Neprilysin Sales Volume by Company (2021-2026)
  4. 3.4 Global Neprilysin Average Price by Company (2021-2026)
  5. 3.5 Global Neprilysin Company Ranking (2024-2026)
  6. 3.6 Global Neprilysin Company Manufacturing Base and Headquarters
  7. 3.7 Global Neprilysin Company Product Type and Application
  8. 3.8 Global Neprilysin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neprilysin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neprilysin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neprilysin Market by Type
  1. 4.1 Neprilysin Type Introduction
  2. 4.1.1 TD-0714
  3. 4.1.2 STR-324
  4. 4.1.3 PL-265
  5. 4.1.4 LHW-090
  6. 4.1.5 Others
  7. 4.2 Global Neprilysin Sales Volume by Type
  8. 4.2.1 Global Neprilysin Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Neprilysin Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Neprilysin Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Neprilysin Sales Value by Type
  12. 4.3.1 Global Neprilysin Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Neprilysin Sales Value by Type (2021-2032)
  14. 4.3.3 Global Neprilysin Sales Value Share by Type (2021-2032)
5 Neprilysin Market by Application
  1. 5.1 Neprilysin Application Introduction
  2. 5.1.1 Acute Heart Failure
  3. 5.1.2 Hypertension
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Alzheimer's Disease
  6. 5.1.5 Others
  7. 5.2 Global Neprilysin Sales Volume by Application
  8. 5.2.1 Global Neprilysin Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Neprilysin Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Neprilysin Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Neprilysin Sales Value by Application
  12. 5.3.1 Global Neprilysin Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Neprilysin Sales Value by Application (2021-2032)
  14. 5.3.3 Global Neprilysin Sales Value Share by Application (2021-2032)
6 Neprilysin Regional Sales and Value Analysis
  1. 6.1 Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neprilysin Sales by Region (2021-2032)
  3. 6.2.1 Global Neprilysin Sales by Region: 2021-2026
  4. 6.2.2 Global Neprilysin Sales by Region (2027-2032)
  5. 6.3 Global Neprilysin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neprilysin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neprilysin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neprilysin Sales Value by Region (2027-2032)
  9. 6.5 Global Neprilysin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neprilysin Sales Value (2021-2032)
  12. 6.6.2 North America Neprilysin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neprilysin Sales Value (2021-2032)
  15. 6.7.2 Europe Neprilysin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neprilysin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neprilysin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neprilysin Sales Value (2021-2032)
  21. 6.9.2 South America Neprilysin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neprilysin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neprilysin Sales Value Share by Country, 2025 VS 2032
7 Neprilysin Country-level Sales and Value Analysis
  1. 7.1 Global Neprilysin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neprilysin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neprilysin Sales by Country (2021-2032)
  4. 7.3.1 Global Neprilysin Sales by Country (2021-2026)
  5. 7.3.2 Global Neprilysin Sales by Country (2027-2032)
  6. 7.4 Global Neprilysin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neprilysin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neprilysin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neprilysin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neprilysin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neprilysin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neprilysin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neprilysin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neprilysin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neprilysin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neprilysin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neprilysin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neprilysin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neprilysin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neprilysin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neprilysin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neprilysin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neprilysin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neprilysin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neprilysin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neprilysin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neprilysin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neprilysin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neprilysin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neprilysin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neprilysin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neprilysin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neprilysin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neprilysin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neprilysin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neprilysin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neprilysin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neprilysin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neprilysin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neprilysin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neprilysin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neprilysin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neprilysin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neprilysin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neprilysin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neprilysin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neprilysin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neprilysin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neprilysin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neprilysin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neprilysin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neprilysin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neprilysin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neprilysin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neprilysin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neprilysin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neprilysin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neprilysin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neprilysin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neprilysin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neprilysin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neprilysin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neprilysin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neprilysin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neprilysin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neprilysin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neprilysin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neprilysin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neprilysin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neprilysin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neprilysin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neprilysin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neprilysin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neprilysin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neprilysin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neprilysin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neprilysin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neprilysin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neprilysin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neprilysin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neprilysin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neprilysin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neprilysin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neprilysin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neprilysin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neprilysin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neprilysin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neprilysin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neprilysin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neprilysin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neprilysin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neprilysin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Neprilysin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Neprilysin Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Theravance Biopharma Inc
  8. 8.2.1 Theravance Biopharma Inc Company Information
  9. 8.2.2 Theravance Biopharma Inc Business Overview
  10. 8.2.3 Theravance Biopharma Inc Neprilysin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Theravance Biopharma Inc Neprilysin Product Portfolio
  12. 8.2.5 Theravance Biopharma Inc Recent Developments
  13. 8.3 Pharmaleads SA
  14. 8.3.1 Pharmaleads SA Company Information
  15. 8.3.2 Pharmaleads SA Business Overview
  16. 8.3.3 Pharmaleads SA Neprilysin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pharmaleads SA Neprilysin Product Portfolio
  18. 8.3.5 Pharmaleads SA Recent Developments
  19. 8.4 Bioprojet SCR
  20. 8.4.1 Bioprojet SCR Company Information
  21. 8.4.2 Bioprojet SCR Business Overview
  22. 8.4.3 Bioprojet SCR Neprilysin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bioprojet SCR Neprilysin Product Portfolio
  24. 8.4.5 Bioprojet SCR Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neprilysin Value Chain Analysis
  2. 9.1.1 Neprilysin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neprilysin Sales Mode & Process
  6. 9.2 Neprilysin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neprilysin Distributors
  9. 9.2.3 Neprilysin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst